Table 4 Complications after treatment and outcome in the study participants
All patients | Renal replacement therapy group | Conservative group | p-value | |
|---|---|---|---|---|
N (%) | N (%) | N (%) | ||
Complications | ||||
Anaemia | 218(57.1) | 34(55.7) | 184(57.3) | < 0.001 |
Fluid Overload | 52(13.6) | 11(18.0) | 41(12.8) | < 0.001 |
Hyperkalaemia | 40(10.5) | 3(4.9) | 37(11.5) | < 0.001 |
Pulmonary oedema | 29(7.6) | 5(8.2) | 24(6.3) | < 0.001 |
Uncontrolled hypertension | 24(6.3) | 6(9.8) | 18(5.6) | 0.014 |
Uremic Gastritis | 11(2.9) | 1(1.6) | 10(3.1) | 0.007 |
Uremic encephalopathy | 7(1.8) | 1(1.6) | 6(1.9) | 0.059 |
Acute rejection | 1(0.3) | 0(0.0) | 1(0.3) | - |
Outcome | ||||
Dead | 8(2.1) | 6(9.8) | 2(0.6) | 0.289 |
Alive | 30(7.3) | 12(19.7) | 18(5.6) | 0.273 |
Lost to follow-up | 337(88.2) | 41(67.2) | 296(92.2) | < 0.001 |
Others | 7(1.8) | 2(3.3) | 5(1.6) | 0.045 |